Related Experiment Videos
Interferon treatment of neuroendocrine tumour xenografts as monitored by MRI
A Elvin1, K Oberg, P G Lindgren
1Department of Diagnostic Radiology, University Hospital, Uppsala, Sweden.
Abstract:
The neuroendocrine-differentiated colonic carcinoma cell line (LCC-18) was transplanted to 29 nude mice (Balb/c). The purpose of the present study was to establish an animal model that would allow monitoring with magnetic resonance imaging (MRI) of changes induced by interferon (IFN) therapy and to evaluate whether the therapeutic response, as expressed by changes in MR signal characteristics and tumour proliferation activity, could be modulated by different IFN dosages. IFN did not seem to have any obvious antiproliferative effect on the LCC-18 tumour cell line transplanted to nude mice and no convincing treatment-related changes in rho values or T1 and T2 relaxation values were observed. The animal model was probably unsuitable for demonstration of IFN effects.
Insights
This study aimed to create an animal model for monitoring interferon (IFN) therapy in colon cancer. However, the model was unsuitable for demonstrating IFN
Area of Science:
- Oncology
- Medical Imaging
- Pharmacology
Background:
- Neuroendocrine-differentiated colonic carcinoma (LCC-18) cell line was utilized.
- Interferon (IFN) therapy is a potential treatment for various cancers.
- Magnetic resonance imaging (MRI) offers non-invasive monitoring capabilities.
Purpose of the Study:
- To establish a nude mouse model for monitoring IFN therapy effects on colon cancer using MRI.
- To evaluate the impact of different IFN dosages on tumor proliferation and MR signal characteristics.
- To assess the suitability of the animal model for demonstrating IFN therapeutic responses.
Main Methods:
- Transplantation of LCC-18 cells into 29 nude mice (Balb/c).
- Administration of varying dosages of interferon (IFN).
- Monitoring tumor changes using magnetic resonance imaging (MRI), including signal characteristics, rho values, and T1/T2 relaxation times.
Main Results:
- Interferon (IFN) showed no significant antiproliferative effect on the transplanted LCC-18 tumor cells.
- No discernible treatment-related changes were observed in MRI parameters (rho values, T1, T2 relaxation times).
- The developed animal model was deemed unsuitable for effectively demonstrating IFN therapy effects.
Conclusions:
- The established nude mouse model with LCC-18 xenografts was not effective in showing the therapeutic impact of interferon.
- Further refinement of the animal model is necessary for future studies investigating IFN efficacy in colon cancer.
- The study highlights challenges in preclinical modeling for evaluating novel cancer therapies.